Effects of immunosuppressive drugs on COVID‐19 severity in patients with autoimmune hepatitis

Liver International · Published 2022-03-01 · Available online 13 Dec 2021 · Journal article · DOI 10.1111/liv.15121 · Cited by 35 (Crossref)

Authors (50)

Cumali Efe, Craig Lammert, Koray Taşçılar, Renumathy Dhanasekaran, Berat Ebik, Fatima Higuera‐de la Tijera, Ali R. Calışkan, Mirta Peralta, Alessio Gerussi, Hatef Massoumi, Andreea M. Catana, Tugrul Purnak, Cristina Rigamonti, Andres J. G. Aldana, Nidah Khakoo, Leyla Nazal, Shalom Frager, Nurhan Demir, Kader Irak, Zeynep Melekoğlu‐Ellik, Hüseyin Kacmaz, Yasemin Balaban, Kadri Atay, Fatih Eren, Mario R. Alvares‐da‐Silva, Laura Cristoferi, Álvaro Urzua, Tuğçe Eşkazan, Bianca Magro, Romee Snijders, Sezgin Barutçu, Ellina Lytvyak, Godolfino M. Zazueta, Aylin Demirezer‐Bolat, Mesut Aydın, Alexandra Heurgue‐Berlot, Eleonora De Martin, Nazım Ekin, Sümeyra Yıldırım, Ahmet Yavuz, Murat Bıyık, Graciela C. Narro, Murat Kıyıcı, Murat Akyıldız, Evrim Kahramanoğlu‐Aksoy, Maria Vincent, Rotonya M Carr, Fulya Günşar, Eira C. Reyes, Murat Harputluoğlu

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Volume

42

Issue

3

Pages

607-614

Year

2022

Citation

Efe, C., Lammert, C., Taşçılar, K., et al. (2022). Effects of immunosuppressive drugs on COVID‐19 severity in patients with autoimmune hepatitis. Liver International. https://doi.org/10.1111/liv.15121

Related articles

• Review article: Immunosuppression in Decompensated Autoimmune Hepatitis Cirrhosis ‐ To Suppress or Not to Suppress? · Alimentary Pharmacology and Therapeutics · 2026 · Cites or is cited by this article
• Enhanced Liver Fibrosis Test, FIB ‐4 and FibroScan : Real‐World Prognostic Accuracy for MASLD in a Biopsy‐Controlled Cohort · Liver International · 2026 · Same journal
• Threshold‐Defined Liver Stiffness Trajectories and Liver‐Related Event Risk in Chronic Liver Disease: A Cohort Study · Liver International · 2026 · Same journal
• Lactulose for Preventing Overt Hepatic Encephalopathy: Between Evidence and Unresolved Questions · Liver International · 2026 · Same journal
• Laparoscopic or Open Liver Resection Versus Multibipolar Radiofrequency Ablation of HCC Within Milan Criteria on Cirrhosis · Liver International · 2026 · Same journal
• Neurofilament Light Chain in Cerebrospinal Fluid and Blood Identifies Patients With Minimal and Overt Hepatic Encephalopathy · Liver International · 2026 · Same journal
• Microtubule‐Targeting Drugs Induce Mesenchymal–Epithelial Transition in Hepatic Stellate Cells · Liver International · 2026 · Same journal
• Burden and Regional Disparities of MASH ‐Related Liver Cancer in the Asia‐Pacific Region From 1990 to 2023 · Liver International · 2026 · Same journal
• High Rates of Advanced Chronic Liver Disease in Patients With Chronic Hepatitis D Virus Infection in Uzbekistan · Liver International · 2026 · Same journal
• Preoperative MRI Intratumoral Heterogeneity Radiomics for Microvascular Invasion and Recurrence‐Free Survival in HCC · Liver International · 2026 · Same journal

Metrics

Citations (Crossref)

35